161 related articles for article (PubMed ID: 37793055)
1. Adopting a new approach to treat refractory or resistant viral infections in solid organ transplant recipients.
Probst V; Thomas SJ; Ouellette CP
Transpl Infect Dis; 2023 Dec; 25(6):e14161. PubMed ID: 37793055
[No Abstract] [Full Text] [Related]
2. Cutaneous infections from viral sources in solid organ transplant recipients.
Ilyas M; Maganty N; Sharma A
J Clin Virol; 2017 Dec; 97():33-37. PubMed ID: 29096391
[TBL] [Abstract][Full Text] [Related]
3. Opportunistic Pulmonary Infections in the Solid Organ Transplant Recipient: A Focus on Drug Therapy.
Goetz ME; Evans RA; Rendulic T
Crit Care Nurs Q; 2017; 40(4):399-413. PubMed ID: 28834861
[TBL] [Abstract][Full Text] [Related]
4. RNA respiratory viral infections in solid organ transplant recipients.
Ison MG; Michaels MG;
Am J Transplant; 2009 Dec; 9 Suppl 4(Suppl 4):S166-72. PubMed ID: 20070677
[No Abstract] [Full Text] [Related]
5. Viral infections in solid organ transplant recipients: novel updates and a review of the classics.
Haidar G; Singh N
Curr Opin Infect Dis; 2017 Dec; 30(6):579-588. PubMed ID: 28984642
[TBL] [Abstract][Full Text] [Related]
6. Prevention and Treatment of Cytomegalovirus Infections in Solid Organ Transplant Recipients.
Koval CE
Infect Dis Clin North Am; 2018 Sep; 32(3):581-597. PubMed ID: 30146024
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus myocarditis in solid organ transplant recipients: A case series and review of literature.
Scherger S; Mathur S; Bajrovic V; Johnson SC; Benamu E; Ramanan P; Wolfel G; Levi ME; Abidi MZ
Transpl Infect Dis; 2020 Jun; 22(3):e13282. PubMed ID: 32232951
[TBL] [Abstract][Full Text] [Related]
8. Role of mTOR inhibitors for the control of viral infection in solid organ transplant recipients.
Pascual J; Royuela A; Fernández AM; Herrero I; Delgado JF; Solé A; Guirado L; Serrano T; de la Torre-Cisneros J; Moreno A; Cordero E; Gallego R; Lumbreras C; Aguado JM;
Transpl Infect Dis; 2016 Dec; 18(6):819-831. PubMed ID: 27600985
[TBL] [Abstract][Full Text] [Related]
9. [Update on the management of cytomegalovirus infection in transplant recipients].
Neofytos D; Van Delden C; Manuel O
Rev Med Suisse; 2023 Apr; 19(822):726-730. PubMed ID: 37057854
[TBL] [Abstract][Full Text] [Related]
10. Arenaviruses and West Nile Virus in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
Anesi JA; Silveira FP;
Clin Transplant; 2019 Sep; 33(9):e13576. PubMed ID: 31022306
[TBL] [Abstract][Full Text] [Related]
11. Real world experience with Maribavir for the treatment of cytomegalovirus in solid organ transplant recipients.
Sabatino DC; Hedvat J; Salerno DM; Pereira MR; Lange NW
Clin Transplant; 2023 Apr; 37(4):e14929. PubMed ID: 36740886
[No Abstract] [Full Text] [Related]
12. Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice.
Razonable RR; Humar A
Clin Transplant; 2019 Sep; 33(9):e13512. PubMed ID: 30817026
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 in solid organ transplant recipients: Initial report from the US epicenter.
Pereira MR; Mohan S; Cohen DJ; Husain SA; Dube GK; Ratner LE; Arcasoy S; Aversa MM; Benvenuto LJ; Dadhania DM; Kapur S; Dove LM; Brown RS; Rosenblatt RE; Samstein B; Uriel N; Farr MA; Satlin M; Small CB; Walsh TJ; Kodiyanplakkal RP; Miko BA; Aaron JG; Tsapepas DS; Emond JC; Verna EC
Am J Transplant; 2020 Jul; 20(7):1800-1808. PubMed ID: 32330343
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey.
Navarro D; San-Juan R; Manuel O; Giménez E; Fernández-Ruiz M; Hirsch HH; Grossi PA; Aguado JM;
Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28859257
[TBL] [Abstract][Full Text] [Related]
15. Viral Hepatitis Recommendations for Solid-Organ Transplant Recipients and Donors.
Faria LC; Terrabuio DRB; Leblebicioglu H; Huprikar S
Transplantation; 2018 Feb; 102(2S Suppl 2):S66-S71. PubMed ID: 29381580
[No Abstract] [Full Text] [Related]
16. New developments in the management of cytomegalovirus infection after solid organ transplantation.
Eid AJ; Razonable RR
Drugs; 2010 May; 70(8):965-81. PubMed ID: 20481654
[TBL] [Abstract][Full Text] [Related]
17. Management of Infections in Solid Organ Transplant Recipients.
Mossad SB
Infect Dis Clin North Am; 2018 Sep; 32(3):xiii-xvii. PubMed ID: 30017490
[No Abstract] [Full Text] [Related]
18. Factors Associated With Genotypic Resistance and Outcome Among Solid Organ Transplant Recipients With Refractory Cytomegalovirus Infection.
Tamzali Y; Pourcher V; Azoyan L; Ouali N; Barrou B; Conti F; Coutance G; Gay F; Tourret J; Boutolleau D
Transpl Int; 2023; 36():11295. PubMed ID: 37398559
[TBL] [Abstract][Full Text] [Related]
19. Preventive Strategies Against Cytomegalovirus and Incidence of α-Herpesvirus Infections in Solid Organ Transplant Recipients: A Nationwide Cohort Study.
Martin-Gandul C; Stampf S; Héquet D; Mueller NJ; Cusini A; van Delden C; Khanna N; Boggian K; Hirzel C; Soccal P; Hirsch HH; Pascual M; Meylan P; Manuel O;
Am J Transplant; 2017 Jul; 17(7):1813-1822. PubMed ID: 28039960
[TBL] [Abstract][Full Text] [Related]
20. Severe infections in critically ill solid organ transplant recipients.
Kalil AC; Sandkovsky U; Florescu DF
Clin Microbiol Infect; 2018 Dec; 24(12):1257-1263. PubMed ID: 29715551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
